---
title: "PHARMASYS INVESTMENTS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/1c8c171c-2e44-52e6-8464-82c4eac2f50d
json: https://whiteintel.dev/api/public/dossier/1c8c171c-2e44-52e6-8464-82c4eac2f50d
identifier: oo:GB-COH-10586191
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# PHARMASYS INVESTMENTS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-10586191`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/1c8c171c-2e44-52e6-8464-82c4eac2f50d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/1c8c171c-2e44-52e6-8464-82c4eac2f50d  

## Ownership & control

### Owners / controllers

- **Greg Lindberg** (beneficial owner) — 100% — https://whiteintel.dev/entity/ae5b7a88-da69-5ede-a1e2-eb3519e6255b
- **Greg Lindberg** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/33381c19-003a-429d-b32b-b7a305064d06
- **LANAS INVESTMENTS (U.K.) LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/8af3c404-caa6-5875-b9b3-c69ecbe0ef71

### Holdings / subsidiaries

- **PHARMASYS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/13f7de76-34e9-52bb-bed9-ebaac552625d
- **PHARMASYS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/13f7de76-34e9-52bb-bed9-ebaac552625d

### UBO chain (walk to the ultimate owner)

A **5-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `10586191`
- **Status:** dissolved
- **Type:** ltd
- **Incorporated:** 2017-01-26
- **Registered office:** Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH, England
- **SIC:** 70100

### Officers

- BEGGS, Howard John — director · Irish · appointed 2017-01-26
- HUNT, Gerard — director · Irish · appointed 2018-01-01
- VAN ROOYEN, Stuart — director · British · appointed 2023-07-17
- LENNON, Ronan — secretary · appointed 2018-01-01 · resigned 2019-07-17
- MORGAN-DOYLE, Jeanne — secretary · appointed 2019-07-17 · resigned 2019-09-30
- O'SULLIVAN, Donal Thomas — secretary · Irish · appointed 2017-01-26 · resigned 2018-01-18
- O'SULLIVAN, Donal Thomas — director · Irish · appointed 2017-01-26 · resigned 2018-01-18

### Beneficial owners (Persons with Significant Control)

- [Clanwilliam Investments (U.K.) Limited](https://whiteintel.dev/entity/8af3c404-caa6-5875-b9b3-c69ecbe0ef71) — 75–100% shares · corporate PSC · United Kingdom — since 2018-11-02
- Greg Lindberg — 75–100% shares · individual PSC · United States — ceased 2018-11-02

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/10586191

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **PHARMASYS INVESTMENTS LIMITED** — https://whiteintel.dev/entity/1c8c171c-2e44-52e6-8464-82c4eac2f50d · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **PHARMASYS INVESTMENTS LIMITED**. Human view: https://whiteintel.dev/entity/1c8c171c-2e44-52e6-8464-82c4eac2f50d · Structured JSON: https://whiteintel.dev/api/public/dossier/1c8c171c-2e44-52e6-8464-82c4eac2f50d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._